| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 10/06/2009 | US7598277 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine |
| 10/06/2009 | US7598272 Kinase inhibitors |
| 10/06/2009 | US7598258 Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of macrophage colony stimulating factor receptor |
| 10/06/2009 | US7598257 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 10/06/2009 | US7598254 Substituted 1,3-thiazolo[5,4-d]pyrimidines as xanthine oxidase inhibitors |
| 10/06/2009 | US7598253 Reverse-turn mimetics and methods relating thereto |
| 10/06/2009 | US7598247 Immunomodulating heterocyclic compounds |
| 10/06/2009 | US7598242 Compounds for the treatment of inflammatory disorders |
| 10/06/2009 | US7598232 Amino-substituted (E)-2,6-dialkoxystyryl 4-substituted-benzylsulfones for treating proliferative disorders |
| 10/06/2009 | US7598228 Administering by direct injection into heart an expression vector comprising a nucleic acid sequence encoding AOP-1 operably linked to a promoter, wherein expression of nucleic acid sequence within cells of heart enhances production of AOP-1, protecting against myocardial cell death |
| 10/06/2009 | US7597889 Recombinant polypeptides and nucleic acids; Graft-vs-host disease, host-vs-graft disease, organ transplant rejection, bone-marrow transplant rejection, autoimmune vasculitis, arthritis or asthma |
| 10/06/2009 | CA2416194C Use of 2-methylene-19-nor-20(s)-1.alpha.,25-dihydroxyvitamin d3 to increase bone strength |
| 10/06/2009 | CA2400461C Method for improving bone modeling and chondrocyte functioning in growing canines |
| 10/06/2009 | CA2301377C N-aroylphenylalanine derivatives |
| 10/01/2009 | WO2009120296A1 Treatment of psoriasis or psoriatic arthritis using cyclopropyl-n-{2-{(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide |
| 10/01/2009 | WO2009119935A1 Method and composition for inducing regeneration of damaged cartilage using microfracture and hyaluronic acid |
| 10/01/2009 | WO2009119836A1 Composition for external application comprising transcription factor decoy as active ingredient |
| 10/01/2009 | WO2009119726A1 Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor |
| 10/01/2009 | WO2009119692A1 Novel glycolipid and use thereof |
| 10/01/2009 | WO2009119652A1 USE OF BENZOPHENONE DERIVATIVE OR SALT THEREOF AND TNF α INHIBITOR IN COMBINATION AND PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVE OR SALT THEREOF AND THE INHIBITOR |
| 10/01/2009 | WO2009117985A1 Pirinixic acid derivatives as prostglandin e2 synthesis inhibitors for treating inflammatory diseases |
| 10/01/2009 | WO2009065922A3 Organic compounds |
| 10/01/2009 | WO2009065919A3 Organic compounds |
| 10/01/2009 | WO2009060835A8 Novel ubiquilin-binding small molecule |
| 10/01/2009 | US20090247741 Process for the production of multiple cross-linked hyaluronic acid derivatives |
| 10/01/2009 | US20090247733 Novel Bone Mineralization Proteins, DNA, Vectors, Expression Systems |
| 10/01/2009 | US20090247731 Boronic ester and acid compounds, synthesis and uses |
| 10/01/2009 | US20090247613 Chemically synthesized nucleic acid molecule with a pyrimidine modification; cancer, ocular disease, and other proliferative disorders; neovascularization, diabetic retinopathy, restenosis and polycystic kidney disease |
| 10/01/2009 | US20090247606 RNA Interference Mediated Inhibition of Adenosine A1 Receptor (ADORA1) Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 10/01/2009 | US20090247492 Manganese based organometallic complexes, pharmaceutical compositions and dietetic products |
| 10/01/2009 | US20090247491 Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof |
| 10/01/2009 | US20090247467 Peptide epitopes of vegfr-2/kdr that inhibit angiogenesis |
| 10/01/2009 | US20090247456 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 10/01/2009 | US20090246855 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |
| 10/01/2009 | US20090246244 Malleable multi-component implants and materials therefor |
| 10/01/2009 | US20090246208 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 10/01/2009 | US20090246201 Substances |
| 10/01/2009 | CA2719290A1 Use of benzophenone derivative or salt thereof and tnf.alpha. inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor |
| 10/01/2009 | CA2718412A1 Treatment of psoriasis or psoriatic arthritis using cyclopropyl-n-{2-{(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide |
| 09/30/2009 | EP2105504A2 Genes and proteins, and their use |
| 09/30/2009 | EP2105497A1 Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom |
| 09/30/2009 | EP2105449A2 Antagonistic selective binding agents of osteoprotegerin binding protein |
| 09/30/2009 | EP2105136A2 Pharmaceutical compositions for treating cancer |
| 09/30/2009 | EP2105135A2 Pharmaceutical compositions for treating cancer |
| 09/30/2009 | EP2104533A2 Use of substances reducing cellular glutathione content for producing a medicament for treating t-cell mediated autoimmune diseases |
| 09/30/2009 | EP1453525B1 Selective targeting of apoptotic cells |
| 09/30/2009 | CN101544631A Novel pyrazole 5-lipoxygenase small molecule inhibitors, preparation method, pharmaceutical composition and application thereof |
| 09/30/2009 | CN101543623A Green healthy bone-strengthening capsule |
| 09/30/2009 | CN101543620A Traditional Chinese medicine preparation for treating rheumatoid arthritis |
| 09/30/2009 | CN101543582A Chinese medicinal ointment for treating osteopathy |
| 09/30/2009 | CN101543580A Traditional Chinese medicine micro pills for treating sciatica and preparation method thereof |
| 09/30/2009 | CN101543568A Yam total sapogenin sustained-release pellet as well as preparation method and application thereof |
| 09/30/2009 | CN101543563A Vein-relaxing bone-nourishing osteophyte-eliminating ointment and method for preparing same |
| 09/30/2009 | CN101543562A Chinese medicament for treating prolapse of lumbar intervertebral disc |
| 09/30/2009 | CN101543556A Traditional Chinese medicine for treating neck vertebrae and lumbar vertebra diseases |
| 09/30/2009 | CN101543551A Traditional Chinese medicine plaster for treating wet rheumatism |
| 09/30/2009 | CN101543523A Uyghur drug compound recipe extracting technology for chiccory |
| 09/30/2009 | CN101543510A Hyperosteogeny medicine |
| 09/30/2009 | CN101543507A Immunostimulatory nucleic acids |
| 09/30/2009 | CN101543504A Pharmaceutical composition for resisting osteoporosis |
| 09/30/2009 | CN101543502A Novel use of salidroside for prevention and cure for osteoporosis |
| 09/30/2009 | CN101543500A Dhea composition and method |
| 09/30/2009 | CN101543492A Novel application of dendrobine |
| 09/30/2009 | CN100544726C DHEA composition and method |
| 09/30/2009 | CN100544715C Composition of free-B-ring flavonoids and flavans as a therapeutic agent |
| 09/29/2009 | US7595399 Tyrosine derivatives |
| 09/29/2009 | US7595342 Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions |
| 09/29/2009 | US7595341 Analogues of lipid mediators derived from ω-3 PUFAs and methods of use |
| 09/29/2009 | US7595317 Antiarthritic agents; rheumatoid and osteoarthritis; corneal, epidermal, or gastric ulceration; tumor metastasis or invasion; periodontal disease; and bone disease; 4-[(2-methyl-4-quinolinyl)methoxy]-N-(1,3,5-trioxo-2,4-diazaspiro[5.5]undec-7-yl)benzamide trifluoroacetate, for example |
| 09/29/2009 | US7595316 2-(1-Cyclopentylpiperidin-4-yloxy)-5-(4-cyanophenyl)pyrimidine, for example; exhibits histamine receptor H3 antagonist or inverse agonist activity and is useful for the treatment and/or prevention of obesity, diabetes, hormonal secretion abnormality, sleep disorders |
| 09/29/2009 | US7595069 rheumatoid arthritis and osteoarthritis; plant extracts of turmeric, devil's claws, meadowsweet, and onagra oil |
| 09/29/2009 | US7595068 Composition comprising Notoginseng radix extract for preventing and treating of arthritis as an effective ingredient |
| 09/29/2009 | CA2469350C 3-{4-methyl-3[methyl-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile mono citrate salt |
| 09/29/2009 | CA2434009C Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 09/29/2009 | CA2403232C 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin d compounds |
| 09/29/2009 | CA2391085C Bis-basic compounds as tryptase inhibitors, processes for preparing them and their use as phamaceutical compositions |
| 09/29/2009 | CA2348391C Chromenone and chromanone derivatives as integrin inhibitors |
| 09/29/2009 | CA2315647C Inhibition of p38 kinase activity using aryl and heteroaryl substituted heterocyclic ureas |
| 09/29/2009 | CA2306573C Process for preparing antiosteoporotic agents |
| 09/29/2009 | CA2273852C Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases |
| 09/29/2009 | CA2100329C Methods for treating tumor necrosis factor mediated diseases |
| 09/24/2009 | WO2009117740A2 Treatment of intervertebral disc degeneration |
| 09/24/2009 | WO2009117584A2 Anti-inflammatory drug delivery system |
| 09/24/2009 | WO2009116888A1 Pharmaceutical composition for preventing and treating bone resorption of different etiology |
| 09/24/2009 | WO2009116546A1 Excitatory chemical mediator and method for screening thereof |
| 09/24/2009 | WO2009116529A1 Polypeptide and pharmaceutical composition containing the polypeptide |
| 09/24/2009 | WO2009115776A1 Cyclopenta[g]quinazoline derivatives for the treatment of rheumatoid arthritis or acute myeloid leukaemia |
| 09/24/2009 | WO2009115651A2 N-phenyl-imidazo[1,2-a]pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof |
| 09/24/2009 | WO2009115525A2 Preparation of a pharmaceutical composition for increasing bone mineral density |
| 09/24/2009 | WO2009087212A3 Pyridine derivatives |
| 09/24/2009 | WO2009076454A3 Compounds that modulate intracellular calcium |
| 09/24/2009 | WO2009065921A3 Novel compounds |
| 09/24/2009 | WO2009058690A3 Nell-1 compositions |
| 09/24/2009 | US20090239917 Heterocyclic Cycloalkyl Compounds, a Process for their Preparation and Pharmaceutical Compositions Containing Them |
| 09/24/2009 | US20090239885 Inhibitors of nucleoside phoshorylases and nucleosidases |
| 09/24/2009 | US20090239877 Novel 1,2,4-triazole derivatives and process of manufacturing thereof |
| 09/24/2009 | US20090239839 Receptor antagonist |
| 09/24/2009 | US20090239828 Adhesive preparation |
| 09/24/2009 | US20090238886 Retro-Inversion Peptides That Target GIT Transport Receptors and Related Methods |
| 09/24/2009 | US20090238829 Stabilized single domain antibodies |